BRANMOOR
THURSDAY · 14 MAY 2026

FDA Recall D-0003-2025

Supercore Products Group Inc. · Atlanta, GA

Class I — life-threatening Ongoing 671 days on record

Highest impact — Class I recall — FDA determination of strong likelihood of serious adverse health consequence or death. Distribution is nationwide and the recall remains in progress.

Product

Hard Steel Capsules packaged in 1 count blister packs in boxes of 10, 20 and 30, Manufactured in U.S.A.

Lot / code: All lots

Quantity: 729

Reason for recall

Marketed without an approved NDA/ANDA: FDA analysis found products to be tainted with undeclared acetaminophen and sildenafil.

Recall record

Recall number
D-0003-2025
Classification
Class I
Status
Ongoing
Voluntary or mandated
Voluntary: Firm initiated
Firm notification
Press Release
Distribution
Nationwide US (2014), Israel (2), Canada (12), Republic of Kosovo (1), Pakistan (1), Australia (3), Morocco (1), United Kingdom (1)
Recall initiated
2024-07-12
Classified by FDA Center
2024-10-02
FDA published
2024-10-09
Recalling firm
Supercore Products Group Inc.
Firm location
Atlanta, GA

Operational response

A Class I recall indicates a strong likelihood of serious adverse health consequence or death. Pull affected lots from active dispensing immediately. Segregate inventory in a marked, locked location pending destruction or return. If product has already been dispensed, identify affected patients and contact them by your standard recall-notification protocol.

For the official FDA enforcement record, see FDA's Recall Search.

‹ All recalls